Results 181 to 190 of about 38,650 (259)

Secondary Hemophagocytic Lymphohistiocytosis as the Initial Presentation of Metastatic Carcinoma of Likely Colorectal Origin. [PDF]

J Brown Hosp Med
Balusu K, Abdelhay A, Sung Eun K, Talal Khan M.   +3 more
europepmc   +1 more source

Novel Combination of UVA‐1 Phototherapy With Topical Tofacitinib for Treating Eosinophilic Fasciitis With Morphea: Case Report

Pediatric Dermatology, EarlyView.
ABSTRACT Eosinophilic fasciitis (EF) and morphea are rare sclerosing connective tissue disorders, and there remains debate about whether these entities are pathologically distinct or related. This case report describes the successful treatment of an adolescent patient who developed progressive morphea plaques while being treated with systemic ...
Daphne M. Cheung, Ye‐Jean Park, Nadia Luca, Frankie Fraulin, Marie‐Anne Brundler, Michele Ramien   +5 more
wiley   +1 more source

Selective vulnerability of human synapses to soluble tau oligomers. [PDF]

J Alzheimers Dis
Kadamangudi S, Sanchez-Sanchez L, Kayed R, Limon A, Taglialatela G.   +4 more
europepmc   +1 more source

Apoptosis kinetics of purified and PBMC‐associated lymphocytes after photopheresis‐like 8‐methoxypsolaren/UVA treatment

Photochemistry and Photobiology, EarlyView.
Extracorporeal photopheresis (ECP) induces apoptosis in circulating immune cells, but its kinetics vary slightly depending on the cell type. We compared the progression of apoptosis in PBMCs versus highly purified T cells exposed to 8‐methoxypsoralen and ultraviolet A.
Carlos Agustin Villegas‐Valverde, Imilla Casado Hernandez, Yandy Marx Castillo‐Aleman, Gisela Maria Suarez‐Formigo, Amar Riaz, Antonio Alfonso Bencomo‐Hernandez, Yendry Ventura‐Carmenate   +6 more
wiley   +1 more source

Effects of photobiomodulation therapy on pulmonary inflammation in chronic asthma: Dosimetric study in an experimental model

Photochemistry and Photobiology, EarlyView.
Photobiomodulation therapy (PBMT) was evaluated across a radiant energy range (1–7.5 J) in a murine model of chronic ovalbumin‐induced asthma to identify the optimal therapeutic dose. PBMT attenuated airway inflammation and remodelling, suppressed Th2 cytokines, and enhanced regulatory immune responses, highlighting a dose‐dependent immunomodulatory ...
Tawany Gonçalves Santos, Cintia Estefano Alves, Bibiana Padilha de Menezes da Silva, Cinthya Cosme Gutierrez Duran, Stella Zamuner, Rodrigo Labat, José Antonio Silva Junior, Maria Cristina Chavantes, Flavio Aimbire, Renata Kelly da Palma, Ana Paula Ligeiro de Oliveira   +10 more
wiley   +1 more source

Making deep immunophenotyping accessible: the successful application of a guided 23-parameter mouse immunophenotyping panel package provided through a shared resource. [PDF]

Front Immunol
Isbell MG, Wendling A, Pei X, Kumar A, Mannangatti P, Krisanits BA, Cheatham S, Michenkova M, Shumilov K, Mendoza RG, Fernandez ME, Bryan A, Nguyen TA, May L, Das SK, Findlay VJ, Akbarali HI, Garcia-Bonilla M, Limbrick DD, Sweet DH, da Rocha SRP, Neuwelt A, Fisher PB, Sarkar D, Wang XY, Landry JW, Martin RK.   +26 more
europepmc   +1 more source

The role of neutrophils in the pathophysiology of inflammatory bowel diseases

Periodontology 2000, EarlyView.
Abstract Objectives Inflammatory bowel disease (IBD) encompasses a spectrum of chronic disorders of the gastrointestinal tract, with a potential bidirectional relationship with periodontitis. Neutrophils are key regulators of immune‐inflammatory responses and play a major role in both diseases.
Joao Paulo Steffens, Ekin Yay‐Kus, Rafael Scaf de Molon, Viorelia Stoica, Peter Rimmer, Josefine Hirschfeld, Asif Jilani Iqbal, Tariq Iqbal, Iain Chapple   +8 more
wiley   +1 more source

The landscape of dynamic tumor immunophenotyping on neoadjuvant chemotherapy combined with trastuzumab for the treatment of HER2-positive breast cancer. [PDF]

Mol Cancer
Jin H, Yang Y, Yan C, Liu M, He X, Yuan D, Zhang W, Mu Y, Wu C, Liu X, Xiao J, Long Q, Li M, Hao X, Zhang Y, Qi W, Liu Y, Yu Z, Guo D, Zhao Z, Li Y, Zhang W, Zhang X.   +22 more
europepmc   +1 more source

Distinct immunophenotypic and clinical features of TP53-mutated acute myeloid leukemia: high CD34/CD41 expression and lower leukocyte counts. [PDF]

Ann Hematol
Park S, Kim SA, Kim S, Kim SY, Lee JY, Byun JM, Hwang SM, Lee JO, Koh Y, Hong J, Chang YH, Kim HK, Bang SM, Kim I, Yoon SS, Shin DY.   +15 more
europepmc   +1 more source